In a recent study by Liu [20], the authors demonstrated significant anti-Alzheimer’s disease potential by testing a variety of bioactive compounds from A. membranaceus, which was also confirmed by molecular docking targeting the AChE enzyme. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.